Filing Details
- Accession Number:
- 0001630998-16-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-02 16:02:11
- Reporting Period:
- 2016-02-01
- Filing Date:
- 2016-02-02
- Accepted Time:
- 2016-02-02 16:02:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610950 | Inc Research Holdings Inc. | INCR | Services-Commercial Physical & Biological Research (8731) | 273403111 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1630998 | Michael Gibertini | C/O Inc Research Holdings, Inc. 3201 Beechleaf Court, Suite 600 Raleigh NC 27604 | President Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2016-02-01 | 9,000 | $8.45 | 56,282 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2016-02-01 | 8,000 | $40.45 | 48,282 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2016-02-01 | 1,000 | $41.56 | 47,282 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2016-02-01 | 9,000 | $0.00 | 9,000 | $8.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 223,644 | 2020-09-28 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b-1 trading plan adopted by the reporting person on September 9, 2015.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.07 to $40.74, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- One half of the shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued employment. The other half of the shares subject to this option vest yearly in five equal installments beginning on December 31, 2013, subject to continued employment.
Billionaire Hedge Funds
